258 related articles for article (PubMed ID: 31406992)
1. Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
Gao M; Bai H; Jethava Y; Wu Y; Zhu Y; Yang Y; Xia J; Cao H; Franqui-Machin R; Nadiminti K; Thomas GS; Salama ME; Altevogt P; Bishop G; Tomasson M; Janz S; Shi J; Chen L; Frech I; Tricot G; Zhan F
J Natl Cancer Inst; 2020 May; 112(5):507-515. PubMed ID: 31406992
[TBL] [Abstract][Full Text] [Related]
2. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
[TBL] [Abstract][Full Text] [Related]
3. FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.
Kim S; Dubrovska A; Salamone RJ; Walker JR; Grandinetti KB; Bonamy GM; Orth AP; Elliott J; Porta DG; Garcia-Echeverria C; Reddy VA
PLoS One; 2013; 8(1):e51671. PubMed ID: 23300950
[TBL] [Abstract][Full Text] [Related]
4. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
Han J; Fujisawa T; Husain SR; Puri RK
BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
[TBL] [Abstract][Full Text] [Related]
7. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Gruber M; Handle F; Culig Z
Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633
[TBL] [Abstract][Full Text] [Related]
8. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
9. CD34
Serizawa K; Tanaka H; Ueda T; Fukui A; Kakutani H; Taniguchi T; Inoue H; Kumode T; Taniguchi Y; Rai S; Hirase C; Morita Y; Espinoza JL; Tatsumi Y; Ashida T; Matsumura I
Int J Hematol; 2022 Mar; 115(3):336-349. PubMed ID: 35133572
[TBL] [Abstract][Full Text] [Related]
10. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.
Deng X; Apple S; Zhao H; Song J; Lee M; Luo W; Wu X; Chung D; Pietras RJ; Chang HR
Oncotarget; 2017 Jun; 8(24):38294-38308. PubMed ID: 28418843
[TBL] [Abstract][Full Text] [Related]
11. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
13. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
[TBL] [Abstract][Full Text] [Related]
14. Identification of CD44+CD24+ gastric cancer stem cells.
Zhang C; Li C; He F; Cai Y; Yang H
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1679-86. PubMed ID: 21882047
[TBL] [Abstract][Full Text] [Related]
15. CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo.
Zimmerer RM; Ludwig N; Kampmann A; Bittermann G; Spalthoff S; Jungheim M; Gellrich NC; Tavassol F
Microvasc Res; 2017 Jul; 112():101-108. PubMed ID: 28344048
[TBL] [Abstract][Full Text] [Related]
16. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
[TBL] [Abstract][Full Text] [Related]
17. IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal.
Gocke CB; McMillan R; Wang Q; Begum A; Penchev VR; Ali SA; Borrello I; Huff CA; Matsui W
Mol Cancer Ther; 2016 Nov; 15(11):2733-2739. PubMed ID: 27573425
[TBL] [Abstract][Full Text] [Related]
18. Identification of pancreatic cancer stem cells.
Li C; Heidt DG; Dalerba P; Burant CF; Zhang L; Adsay V; Wicha M; Clarke MF; Simeone DM
Cancer Res; 2007 Feb; 67(3):1030-7. PubMed ID: 17283135
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.
Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801
[TBL] [Abstract][Full Text] [Related]
20. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
Huang G; Jiang H; Lin Y; Xia W; Luo Y; Wu Y; Cai W; Zhou X; Jiang X
J Exp Clin Cancer Res; 2018 Jun; 37(1):121. PubMed ID: 29925408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
